Grifols, S.A.

Grifols, S.A.verified

GRFS

Price:

$8.7

Market Cap:

$6.69B

Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solutions to treat patients with chronic, rare, prevalent, and life-threatening diseases. It offers immunoglobulins, alpha-1 antitrypsin, albumin, clotting factors, and hyperimmune globulins. The Hospital division offers non-biological pharmaceutical products and medical supplies clinical nutrition, intravenous therapy, and medical devices. The Diagnostic ...[Read more]

Industry

Drug Manufacturers - General

IPO Date

2011-06-02

Stock Exchange

NASDAQ

Ticker

GRFS

The Enterprise Value as of November 2024 (TTM) for Grifols, S.A. (GRFS) is 6.05B

According to Grifols, S.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 6.05B. This represents a change of -52.35% compared to the average of 12.69B of the last 4 quarters.

Grifols, S.A. (GRFS) Historical Enterprise Value (quarterly & annually)

How has GRFS Enterprise Value performed in the past?

The mean historical Enterprise Value of Grifols, S.A. over the last ten years is 15.96B. The current 6.05B Enterprise Value has changed 3.69% with respect to the historical average. Over the past ten years (40 quarters), GRFS's Enterprise Value was at its highest in in the December 2019 quarter at 20.70B. The Enterprise Value was at its lowest in in the September 2022 quarter at 4.27B.

Quarterly (TTM)
Annual

Average

15.96B

Median

15.79B

Minimum

12.78B

Maximum

20.59B

Grifols, S.A. (GRFS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Grifols, S.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 28.06%

Maximum Annual Enterprise Value = 20.59B

Minimum Annual Increase = -19.10%

Minimum Annual Enterprise Value = 12.78B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202316.69B14.41%
202214.59B-5.09%
202115.37B-7.74%
202016.66B-19.10%
201920.59B26.98%
201816.22B-12.16%
201718.46B28.06%
201614.42B4.17%
201513.84B8.26%
201412.78B17.04%

Grifols, S.A. (GRFS) Average Enterprise Value

How has GRFS Enterprise Value performed in the past?

The current Enterprise Value of Grifols, S.A. (GRFS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

15.55B

5-year avg

16.78B

10-year avg

15.96B

Grifols, S.A. (GRFS) Enterprise Value vs. Peers

How is GRFS’s Enterprise Value compared to its peers?

Grifols, S.A.’s Enterprise Value is less than Novartis AG (222.57B), less than AstraZeneca PLC (230.26B), less than GSK plc (52.06B), less than Roche Holding AG (234.35B), less than Bristol-Myers Squibb Company (162.91B), less than Merck & Co., Inc. (274.43B), less than Gilead Sciences, Inc. (135.65B), less than Amgen Inc. (209.71B), less than Biogen Inc. (27.96B), less than Sanofi (133.10B),

CompanyEnterprise ValueMarket cap
222.57B$204.02B
230.26B$203.49B
52.06B$69.26B
234.35B$227.29B
162.91B$119.40B
274.43B$250.89B
135.65B$112.40B
209.71B$158.32B
27.96B$23.01B
133.10B$121.05B

Build a custom stock screener for Grifols, S.A. (GRFS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Grifols, S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Grifols, S.A. (GRFS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Grifols, S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Grifols, S.A.'s Enterprise Value?

What is the highest Enterprise Value for Grifols, S.A. (GRFS)?

What is the 3-year average Enterprise Value for Grifols, S.A. (GRFS)?

What is the 5-year average Enterprise Value for Grifols, S.A. (GRFS)?

How does the current Enterprise Value for Grifols, S.A. (GRFS) compare to its historical average?